FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: NASDAQ:PCRX

Sort
E.g., 2013-05-21
E.g., 2013-05-21
Enter a comma separated list of user names.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX) witnessed volume of 610,058 shares during last trade however it holds an average trading capacity of 105,511.00 shares. PCRX last trade opened at $10.51 reached intraday low of $9.30 and went -2.21% down to close at $10.18.

Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) an emerging specialty pharmaceutical company, announced that additional safety data are being highlighted from its Phase 3 trial of EXPARELâ„¢ (bupivacaine extended-release liposome injection) in bunionectomy. The data showed comparable safety in wound healing and significantly improved efficacy in pain reduction compared to placebo.

Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) an emerging specialty pharmaceutical company, announced that additional safety data are being highlighted from its Phase 3 trial of EXPARELâ„¢ (bupivacaine extended-release liposome injection) in bunionectomy. The data showed comparable safety in wound healing and significantly improved efficacy in pain reduction compared to placebo.

ADVERTISE WITH US